Zuo and colleagues set out to determine laboratory markers, transplant-related factors, and other systemic manifestations associated with vitiligo and/or alopecia areata in patients with chronic graft-vs-host disease.
This prospective questionnaire-based study suggests that eczema in adulthood is a previously unrecognized risk factor for fracture and other injury causing limitation.
Lim et al evaluate the efficacy and safety of combination therapy for generalized vitiligo consisting of afamelanotide implant and narrowband UV-B (NB–UV-B) phototherapy.
Sanlorenzo and colleagues assess the risk of melanoma in pilots and airline crew.
This observational study reports that indoor tanning facilities are widely available on or near college campuses and suggests that decreasing their availability could reduce skin cancer risk in young adults.
In this case series, the authors determine novel major and minor criteria for diagnosis of ichthyosis with confetti (IWC), both before and after the appearance of healthy skin spots, finding that ectodermal malformations, present in all patients, suggest a novel classification of IWC as a syndrome.
Cusack et al describe a man with a history of orthotopic heart transplant, immunosuppressed with low-dose cyclosporine, with multiple, recurrent, locally aggressive facial basal cell carcinomas (BCCs), who was started on vismodegib therapy.
This observational study found brentuximab to be a well-tolerated, promising new treatment option for advanced cutaneous T-cell lymphoma.
This case series describes what appear to be the first instances of a dusky erythema associated with the use of MEK inhibitors.
Van Boheemen and colleagues describe a case of follicular spicules in a patient with multiple myeloma and attempted to identify a possible viral cause and to classify this enigmatic entity.
This consensus statement gives treatment recommendations for 4 clinical nail psoriasis scenarios that were developed based on the evidence reviewed and expert opinion from the Medical Board of the National Psoriasis Foundation.